Dynamic Technology Lab Private Ltd Makes New Investment in MKS Inc. $MKSI

Dynamic Technology Lab Private Ltd purchased a new stake in MKS Inc. (NASDAQ:MKSI) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 3,270 shares of the scientific and technical instruments company’s stock, valued at approximately $405,000.

Other large investors have also recently modified their holdings of the company. Norges Bank acquired a new position in shares of MKS during the second quarter worth $85,391,000. Frontier Capital Management Co. LLC increased its holdings in MKS by 146.4% in the second quarter. Frontier Capital Management Co. LLC now owns 912,380 shares of the scientific and technical instruments company’s stock valued at $90,654,000 after purchasing an additional 542,094 shares during the period. Channing Capital Management LLC raised its position in MKS by 79.3% during the 2nd quarter. Channing Capital Management LLC now owns 991,298 shares of the scientific and technical instruments company’s stock worth $98,495,000 after purchasing an additional 438,338 shares during the last quarter. Rafferty Asset Management LLC raised its position in MKS by 63.4% during the 2nd quarter. Rafferty Asset Management LLC now owns 878,114 shares of the scientific and technical instruments company’s stock worth $87,249,000 after purchasing an additional 340,645 shares during the last quarter. Finally, Westfield Capital Management Co. LP acquired a new position in MKS during the 3rd quarter worth about $40,023,000. Institutional investors own 99.79% of the company’s stock.

MKS Trading Down 0.5%

Shares of MKS stock opened at $224.25 on Thursday. The company has a debt-to-equity ratio of 1.53, a quick ratio of 1.71 and a current ratio of 2.71. MKS Inc. has a 52 week low of $54.84 and a 52 week high of $269.91. The stock has a 50 day moving average price of $224.65 and a two-hundred day moving average price of $168.72. The stock has a market capitalization of $15.08 billion, a PE ratio of 51.32, a price-to-earnings-growth ratio of 1.24 and a beta of 1.94.

MKS (NASDAQ:MKSI) last issued its earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.47 earnings per share for the quarter, missing analysts’ consensus estimates of $2.51 by ($0.04). MKS had a return on equity of 20.85% and a net margin of 7.53%.The firm had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same period in the previous year, the company earned $2.15 earnings per share. MKS’s revenue for the quarter was up 10.5% compared to the same quarter last year. MKS has set its Q1 2026 guidance at 1.720-2.280 EPS. As a group, equities analysts anticipate that MKS Inc. will post 6.94 earnings per share for the current fiscal year.

MKS Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 6th. Shareholders of record on Monday, February 23rd were issued a dividend of $0.25 per share. The ex-dividend date was Monday, February 23rd. This is a positive change from MKS’s previous quarterly dividend of $0.22. This represents a $1.00 annualized dividend and a yield of 0.4%. MKS’s dividend payout ratio is currently 22.88%.

Key Stories Impacting MKS

Here are the key news stories impacting MKS this week:

• Positive Sentiment: Zacks Research raised earnings estimates across multiple quarters and moved to a “Strong‑Buy,” lifting FY2027 and FY2028 forecasts materially (FY2027 to $9.98 and FY2028 to $14.56), implying stronger future growth expectations for MKS. This analyst backing can support upward momentum.
• Positive Sentiment: Brokerage sentiment has been turning favorable — several firms (Citigroup, Deutsche Bank, Cantor Fitzgerald, Morgan Stanley) have raised price targets and reiterated buy/overweight ratings; MarketBeat shows a consensus “Moderate Buy” with an average target ~ $273.46 — positive for investor sentiment.
• Positive Sentiment: Dividend hike: MKS increased the quarterly dividend to $0.25 ($1.00 annualized) from $0.22, keeping payout ratio modest (~23%) and signaling confidence in cash flow. This supports income-oriented demand.
• Positive Sentiment: Large institutional inflows: notable new and expanded stakes from Norges Bank, Southpoint, Frontier Capital, Westfield and Millennium show strong institutional conviction and add stability to the shareholder base.
• Neutral Sentiment: MKS benefited from improving end markets per an investor letter summary (Madison Investments), suggesting demand pickup that could sustain top-line growth. MKS (MKSI) Gained from End Markets Picking Up
• Neutral Sentiment: Recent quarterly results showed revenue beat (+10.5% YoY to ~$1.03B) but a slight EPS miss (-$0.04). Management issued Q1 guidance (EPS 1.72–2.28) — mixed near‑term read but evidence of ongoing growth.
• Negative Sentiment: Insider selling: EVP Eric Taranto sold 4,568 shares (avg ~$220.52) and has trimmed his holdings substantially across February/March, which some investors view as a negative signal. Eric Robert Taranto Sells 4,568 Shares of MKS
• Negative Sentiment: Short interest rose ~20% in February to ~3.84M shares (~5.7% of float). Elevated short activity can add volatility and downward pressure on near‑term price action.

Wall Street Analyst Weigh In

A number of research firms have commented on MKSI. Weiss Ratings reiterated a “hold (c)” rating on shares of MKS in a research report on Thursday, January 22nd. KeyCorp restated an “overweight” rating and set a $310.00 price objective on shares of MKS in a research report on Wednesday, February 18th. Wells Fargo & Company upped their target price on MKS from $210.00 to $255.00 and gave the company an “equal weight” rating in a report on Thursday, February 19th. Citigroup increased their target price on shares of MKS from $185.00 to $295.00 and gave the company a “buy” rating in a research report on Thursday, February 19th. Finally, Wall Street Zen lowered shares of MKS from a “strong-buy” rating to a “buy” rating in a report on Saturday, January 3rd. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, MKS presently has a consensus rating of “Moderate Buy” and an average price target of $273.46.

Insider Activity

In other MKS news, Director Gerald G. Colella sold 10,000 shares of the firm’s stock in a transaction on Tuesday, February 24th. The shares were sold at an average price of $253.97, for a total value of $2,539,700.00. Following the transaction, the director directly owned 40,017 shares of the company’s stock, valued at approximately $10,163,117.49. This trade represents a 19.99% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Kathleen Flaherty Burke sold 4,254 shares of MKS stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $250.00, for a total transaction of $1,063,500.00. Following the transaction, the executive vice president owned 53,794 shares of the company’s stock, valued at $13,448,500. This represents a 7.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 68,163 shares of company stock valued at $17,215,417. 0.57% of the stock is currently owned by insiders.

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.